---
figid: PMC4534527__zlj9991053700001
figtitle: Illustration of sonic hedgehog (SHH) signaling pathway
organisms:
- Homo sapiens
pmcid: PMC4534527
filename: zlj9991053700001.jpg
figlink: /pmc/articles/PMC4534527/figure/F1/
number: F1
caption: Illustration of sonic hedgehog (SHH) signaling pathway. (1) SHH ligand binds
  to PTCH1 transmembrane protein. (2) Binding of SHH to PTCH1 relieves inhibition
  of smoothened (SMO). (3) Activated SMO localizes to cilium. (4) SMO releases suppressor
  of fused (SUFU) inhibition of GLI proteins. (5) Activated GLI proteins translocate
  to nucleus and activate transcription of SHH target genes (ie, GLI1, GLI2, PTCH1,
  and MYCN). In SHH-subgroup medulloblastoma, disruptions to SHH pathway occur through
  mutation of PTCH1, SMO, or SUFU and/or amplification of GLI2 or MYCN. Vismodegib
  inhibits SMO.
papertitle: 'Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehogâ€“Subgroup
  Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies
  PBTC-025B and PBTC-032.'
reftext: Giles W. Robinson, et al. J Clin Oncol. 2015 Aug 20;33(24):2646-2654.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9476337
figid_alias: PMC4534527__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4534527__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4534527__zlj9991053700001.html
  '@type': Dataset
  description: Illustration of sonic hedgehog (SHH) signaling pathway. (1) SHH ligand
    binds to PTCH1 transmembrane protein. (2) Binding of SHH to PTCH1 relieves inhibition
    of smoothened (SMO). (3) Activated SMO localizes to cilium. (4) SMO releases suppressor
    of fused (SUFU) inhibition of GLI proteins. (5) Activated GLI proteins translocate
    to nucleus and activate transcription of SHH target genes (ie, GLI1, GLI2, PTCH1,
    and MYCN). In SHH-subgroup medulloblastoma, disruptions to SHH pathway occur through
    mutation of PTCH1, SMO, or SUFU and/or amplification of GLI2 or MYCN. Vismodegib
    inhibits SMO.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMO
  - SMOX
  - SUFU
  - GLI2
  - GLI3
  - SHH
  - GLI1
  - PTCH1
  - CCND1
  - MYCN
  - Cancer
---
